MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/110/0.1/20.12.24 Stock

Warrant

DE000MG4D2V1

Real-time Bid/Ask 07:59:26 2024-06-26 EDT
0.123 EUR / 0.162 EUR +4.38% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/110/0.1/20.12.24
Current month-75.54%
1 month-87.88%
Date Price Change
24-06-26 0.124 -9.49%
24-06-25 0.137 -24.73%
24-06-24 0.182 -9.00%
24-06-21 0.2 -1.48%
24-06-20 0.203 -11.74%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 07:58 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2V
ISINDE000MG4D2V1
Date issued 2024-05-16
Strike 110 $
Maturity 2024-12-20 (177 Days)
Parity 10 : 1
Emission price 1.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.24
Lowest since issue 0.124
Spread 0.023
Spread %15.65%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
55.86 USD
Average target price
83.43 USD
Spread / Average Target
+49.36%
Consensus